Development of predictors for PD-1/PD-L1-directed therapy of non-small cell lung cancer (NSCLC) by gene expression profiling of small diagnostic biopsies (DBX). - Fabian Dominik Mairinger, Marcel Wiesweg, Simon Bogner, Balazs Hegedues, Henning Reis, Moritz Goetz, Thomas Herold, Robert Walter, Thomas Hager, Kaid Darwiche, Martin Metzenmacher, Wilfried Ernst Erich Eberhardt, Ken Herrmann, Kurt Werner Schmid, Clemens Aigner - Dissemin

Language
Login

Published in

American Society of Clinical Oncology, Journal of Clinical Oncology, 15_suppl(36), p. e15121-e15121

DOI: 10.1200/jco.2018.36.15_suppl.e15121

Links

Tools

Export citation

Search in Google Scholar

Development of predictors for PD-1/PD-L1-directed therapy of non-small cell lung cancer (NSCLC) by gene expression profiling of small diagnostic biopsies (DBX).

Journal article published in 2018 by Fabian Dominik Mairinger, Marcel Wiesweg, Simon Bogner, Balazs Hegedues, Henning Reis, Moritz Goetz, Thomas Herold, Robert Walter, Thomas Hager, Kaid Darwiche, Martin Metzenmacher, Wilfried Ernst Erich Eberhardt, Ken Herrmann, Kurt Werner Schmid, Clemens Aigner

ORCID

and other authors.

This paper is made freely available by the publisher.

This paper is made freely available by the publisher.

Full text: Download

Red circle

Preprint: archiving forbidden

Orange circle

Postprint: archiving restricted

Upload

Red circle

Published version: archiving forbidden

Policy details

Data provided by

SHERPA/RoMEO